Host central nervous system cells (CNS cells)

Host central nervous system (CNS) cells represent the primary functional units of the brain and spinal cord, consisting of neurons and various glial cells such as astrocytes, microglia, and oligodendrocytes (StatPearls, 2023). These cells are responsible for the integration of sensory input, the execution of motor commands, and the maintenance of cognitive and homeostatic functions through intricate synaptic and chemical signaling (NIH, 2024). While not a single molecular target, CNS cells house the receptors, transporters, and enzymes that serve as the actual targets for a wide range of pharmacological interventions aimed at treating neurological and psychiatric disorders. Pathological changes in these cells, such as protein aggregation or neuroinflammation, are hallmarks of diseases like Alzheimer's, Parkinson's, and multiple sclerosis (PubMed, 2022). Therapeutic targeting of CNS cells is uniquely complicated by the blood-brain barrier (BBB), which restricts the entry of many systemic drugs, and the potential for profound side effects due to the complexity of neural networks (Frontiers in Pharmacology, 2020).

Other names

Central nervous system cellsCNS cellsNeural cellsBrain and spinal cord cellsHost neural tissue

Drugs acting on host central nervous system cells typically modulate neurotransmission, ion channel activity, or enzymatic pathways within neurons and glial cells to alter physiological or pathological states (StatPearls, 2023). These agents often target specific receptors (e.g., GPCRs, ionotropic receptors) or transporters located on the cell membranes of these neural populations (PubMed, 2021).